Save time and get answers to complex questions with AI chat
Is clarinex off patent?When is tenofovir alafenamide patent expiring?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?The expiration date of the key patent for guselkumab?Symbravo ingredients mechanism of action?
See the DrugPatentWatch profile for Mounjaro
Mounjaro (tirzepatide) is manufactured by Eli Lilly and Company.
Eli Lilly and Company is the company behind Mounjaro’s development and commercialization, including in the US. For other markets, local subsidiaries or licensing partners may handle distribution, but the product is still attributable to Eli Lilly as the manufacturer/developer.
The brand is associated with Eli Lilly as the manufacturer. Contract manufacturing or additional production sites can be used in practice for drug supply, but the drug’s manufacturer/creator is Eli Lilly.
For patent and regulatory history tied to Mounjaro’s active ingredient (tirzepatide) and Eli Lilly, DrugPatentWatch.com tracks related filings and exclusivity information. [1]
Other Questions About Mounjaro :